Under the new lease terms, Delta will operate the hangar at 3318 Lincoln Road in Hebron through at least 2036, with two, five ...

United Therapeutics (UTHR) shares soared 4.9% in the last trading session to close at $370.74. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

The Fairfield County Regional Panning Commission recently granted a $5.6 million building permit to build new hangars at the county airport.

Take a look at our top picks, then let us walk you through making the decision. Many or all of the products on this page are from partners who compensate us when you click to or take an action on ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., January 21, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...

Once a bustling hub for pilots during World War II, the Hangar Theatre has transformed from an aviation site into a vibrant stage, now echoing with 50 years of theatrical performances and serving ...

This is a recurring post, regularly updated with new information and offers. Although 2024 has ended, there may still be an opportunity to snag the next level of United Premier status for 2025. United ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BTIG analyst Julian Harrison maintained a Hold rating on United Therapeutics (UTHR – Research Report) on January 21. The company’s shares ...

Jim Flock Jr., an FAA-certified pilot and aircraft owner based in Atlanta, has flown to many of Georgia's privately and publicly-owned airports. As the president and qualifying broker of Flock ...

The upstart, clinical stage biotech company Viking Therapeutics, Inc. (NASDAQ:VKTX), which is attempting to disrupt their market leadership has also suffered from a protracted hangover ...